International Journal of Hematology

, Volume 80, Issue 1, pp 43–51 | Cite as

Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings

  • Yasushi Onishi
  • Yoshihiro Matsuno
  • Ukihide Tateishi
  • Akiko Miyagi Maeshima
  • Masahiko Kusumoto
  • Takashi Terauchi
  • Shigeru Kusumoto
  • Naohiro Sekiguchi
  • Kazuki Tanimoto
  • Takashi Watanabe
  • Yukio Kobayashi
  • Kensei Tobinai
Article

Abstract

Precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) presents a mediastinal mass in one half of cases. Although the immunophenotypic features of T-ALL/LBL have been analyzed in several studies, few studies have been focused on the relationship between the anatomic distribution of lesions and immunophenotypic findings.We analyzed the clinicopathologic findings for 17 patients with T-ALL/LBL diagnosed since 1993 and whose radiologic findings were available. Data on 14 men and 3 women with a median age of 26 years (range, 10–61 years) were analyzed. On the basis of radiologic findings, the cases were divided into thymic type (n = 8) and nonthymic type (n = 9). Patients with the thymic type of T-ALL/LBL had a large mediastinal mass and minimal systemic lymphadenopathy only in the supradiaphragmatic region.Those with the nonthymic type had predominantly systemic lymphadenopathy that included infradiaphragmatic lesions. Expression of CD8 (6/7 versus 0/9) was more frequently found in the thymic type (P < .001), whereas expression of CD56 (0/7 versus 5/9) was more frequent in the nonthymic type (P = .034). In conclusion,T-ALL/LBL was divided into 2 entities, thymic type and nonthymic type, on the basis of radiologic findings and immunophenotypic features. Analysis of the expression of CD8 and CD56 would be useful for biologically classifying T-ALL/LBL into the 2 types. This study was performed in a single institution, was retrospective, and had a limited number of patients; multicenter confirmatory studies are warranted.

Key words

Precursor T-cell lymphoblastic lymphoma Radiologic findings Mediastinal mass Immunophenotype CD56 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nathwani BN, Diamond LW, Winberg CD, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer. 1981; 48:2347–2357.CrossRefPubMedGoogle Scholar
  2. 2.
    Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976;38:964–983.CrossRefPubMedGoogle Scholar
  3. 3.
    Streuli RA, Kaneko Y, Variakojis D, Kinnealey A, Golomb HM, Rowley JD. Lymphoblastic lymphoma in adults. Cancer. 1981;47: 2510–2516.CrossRefPubMedGoogle Scholar
  4. 4.
    Griffith RC, Kelly DR, Nathwani BN, et al. A morphologic study of childhood lymphoma of the lymphoblastic type: the Pediatric Oncology Group experience. Cancer. 1987;59:1126–1131.CrossRefPubMedGoogle Scholar
  5. 5.
    Baldit C, Trojani M, Eghbali H, Hoerni-Simon G, Hoerni B. Lymphoblastic lymphoma with convoluted nuclei: a report of 19 cases. Oncology. 1984;41:252–256.CrossRefPubMedGoogle Scholar
  6. 6.
    Morel P, Lepage E, Brice P, et al. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol. 1992;10:1078–1085.CrossRefPubMedGoogle Scholar
  7. 7.
    Brunning RD, Borowitz M, Matutes E, et al. Precursor T lymphoblastic leukaemia/lymphoblastic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics—Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:115–117.Google Scholar
  8. 8.
    Bernard A, Boumsell L, Reinherz EL, et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981;57:1105–1110.PubMedGoogle Scholar
  9. 9.
    Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res. 1983;43:4486–4490.PubMedGoogle Scholar
  10. 10.
    Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986; 67:474–478.PubMedGoogle Scholar
  11. 11.
    Feller AC, Parwaresch MR, Stein H, Ziegler A, Herbst H, Lennert K. Immunophenotyping of T-lymphoblastic lymphoma/leukemia: correlation with normal T-cell maturation. Leuk Res. 1986;10:1025–1031.CrossRefPubMedGoogle Scholar
  12. 12.
    Knowles DM. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol. 1989;134: 761–785.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Swerdlow SH, Habeshaw JA, Richards MA, Rainey M, Murray LJ, Stansfeld AG. T lymphoblastic lymphoma with LEU-7 positive phenotype and unusual clinical course: a multiparameter study. Leuk Res. 1985;9:167–173.CrossRefPubMedGoogle Scholar
  14. 14.
    Sheibani K, Winberg CD, Burke JS, et al.Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. Leuk Res. 1987;11:371–377.CrossRefPubMedGoogle Scholar
  15. 15.
    Sheibani K, Nathwani BN,Winberg CD, et al. Antigenically defined subgroups of lymphoblastic lymphoma: relationship to clinical presentation and biologic behavior. Cancer. 1987;60:183–190.CrossRefPubMedGoogle Scholar
  16. 16.
    Pirruccello SJ, Bicak MS, Gordon BG, Gajl-Peczalska K, Gnarra DJ, Coccia PF. Acute lymphoblastic leukemia of NK-cell lineage: responses to IL-2. Leuk Res. 1989;13:735–743.CrossRefPubMedGoogle Scholar
  17. 17.
    Kawano S, Tatsumi E,Yoneda N, et al. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient. Hematol Oncol. 1995;13:1–11.CrossRefPubMedGoogle Scholar
  18. 18.
    Ichinohasama R, Endoh K, Ishizawa K, et al. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report. Cancer. 1996;77:2592–2603.CrossRefPubMedGoogle Scholar
  19. 19.
    Koita H, Suzumiya J, Ohshima K, et al. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol. 1997;21:242–248.CrossRefPubMedGoogle Scholar
  20. 20.
    Nakamura S, Koshikawa T, Yatabe Y, Suchi T. Lymphoblastic lymphoma expressing CD56 and TdT. Am J Surg Pathol. 1998;22: 135–137.PubMedGoogle Scholar
  21. 21.
    Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994;180:569–576.CrossRefPubMedGoogle Scholar
  22. 22.
    Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503–517.CrossRefPubMedGoogle Scholar
  23. 23.
    Mitchell CD, Gordon I, Chessells JM. Clinical, haematological, and radiological features in T-cell lymphoblastic malignancy in childhood. Clin Radiol. 1986;37:257–261.CrossRefPubMedGoogle Scholar
  24. 24.
    Kjeldsberg CR,Wilson JF, Berard CW. Non-Hodgkin’s lymphoma in children. Hum Pathol. 1983;14:612–627.CrossRefPubMedGoogle Scholar
  25. 25.
    Kobashi Y, Nakamura S, Sasajima Y, et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology. 1996;28:111–120.CrossRefPubMedGoogle Scholar
  26. 26.
    Nakamura S, Suchi T,Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol. 1995;19:284–296.CrossRefPubMedGoogle Scholar
  27. 27.
    Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/ natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417–2428.PubMedGoogle Scholar
  28. 28.
    Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res. 1999;23:615–624.CrossRefPubMedGoogle Scholar
  29. 29.
    Suzuki R, Murata M, Kami M, et al. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0. Int J Hematol. 2003;77:482–489.CrossRefPubMedGoogle Scholar
  30. 30.
    Karube K, Ohshima K, Tsuchiya T, et al. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification. Am J Surg Pathol. 2003;27:1366–1374.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Yasushi Onishi
    • 1
  • Yoshihiro Matsuno
    • 2
  • Ukihide Tateishi
    • 3
  • Akiko Miyagi Maeshima
    • 4
  • Masahiko Kusumoto
    • 3
  • Takashi Terauchi
    • 3
  • Shigeru Kusumoto
    • 1
  • Naohiro Sekiguchi
    • 1
  • Kazuki Tanimoto
    • 1
  • Takashi Watanabe
    • 1
  • Yukio Kobayashi
    • 1
  • Kensei Tobinai
    • 1
  1. 1.Hematology DivisionNational Cancer Center HospitalTokyoJapan
  2. 2.Clinical LaboratoryNational Cancer Center HospitalJapan
  3. 3.Diagnostic Radiology DivisionsNational Cancer Center HospitalJapan
  4. 4.Pathology DivisionNational Cancer Center Research InstituteTokyoJapan

Personalised recommendations